These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 16952007)

  • 21. Differential regulation of nicotinic acetylcholine receptors in PC12 cells by nicotine and nerve growth factor.
    Avila AM; Dávila-García MI; Ascarrunz VS; Xiao Y; Kellar KJ
    Mol Pharmacol; 2003 Oct; 64(4):974-86. PubMed ID: 14500754
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Displacement and nonlinear chromatographic techniques in the investigation of interaction of noncompetitive inhibitors with an immobilized alpha3beta4 nicotinic acetylcholine receptor liquid chromatographic stationary phase.
    Jozwiak K; Haginaka J; Moaddel R; Wainer IW
    Anal Chem; 2002 Sep; 74(18):4618-24. PubMed ID: 12349962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions of narcotics an their antagonists with human serum esterase. IX: structure-activity relationships of morphinans and morphines.
    Bamberger MJ; Gero A
    Arch Int Pharmacodyn Ther; 1981 Feb; 249(2):189-202. PubMed ID: 7224721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of noncompetitive inhibitors with the alpha3beta2 nicotinic acetylcholine receptor investigated by affinity chromatography and molecular docking.
    Jozwiak K; Ravichandran S; Collins JR; Moaddel R; Wainer IW
    J Med Chem; 2007 Nov; 50(24):6279-83. PubMed ID: 17973360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence that nicotinic alpha(7) receptors are not involved in the hyperlocomotor and rewarding effects of nicotine.
    Grottick AJ; Trube G; Corrigall WA; Huwyler J; Malherbe P; Wyler R; Higgins GA
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1112-9. PubMed ID: 10945867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Agonist-induced hump current production in heterologously-expressed human alpha4beta2-nicotinic acetylcholine receptors.
    Liu Q; Yu KW; Chang YC; Lukas RJ; Wu J
    Acta Pharmacol Sin; 2008 Mar; 29(3):305-19. PubMed ID: 18298895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism-based approach to the successful prevention of cocaine inhibition of the neuronal (alpha 3 beta 4) nicotinic acetylcholine receptor.
    Krivoshein AV; Hess GP
    Biochemistry; 2004 Jan; 43(2):481-9. PubMed ID: 14717603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of 3,6-diazabicyclo[3.1.1]heptanes as novel ligands for neuronal nicotinic acetylcholine receptors.
    Murineddu G; Murruzzu C; Curzu MM; Chelucci G; Gotti C; Gaimarri A; Legnani L; Toma L; Pinna GA
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6147-50. PubMed ID: 18938077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular modeling of human pentameric alpha(7) neuronal nicotinic acetylcholine receptor and its interaction with its agonist and competitive antagonist.
    Parthiban M; Rajasekaran MB; Ramakumar S; Shanmughavel P
    J Biomol Struct Dyn; 2009 Apr; 26(5):535-47. PubMed ID: 19236104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential expression of the beta4 neuronal nicotinic receptor subunit affects tolerance development and nicotinic binding sites following chronic nicotine treatment.
    Meyers EE; Loetz EC; Marks MJ
    Pharmacol Biochem Behav; 2015 Mar; 130():1-8. PubMed ID: 25560939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The motivational valence of nicotine in the rat ventral tegmental area is switched from rewarding to aversive following blockade of the alpha7-subunit-containing nicotinic acetylcholine receptor.
    Laviolette SR; van der Kooy D
    Psychopharmacology (Berl); 2003 Mar; 166(3):306-13. PubMed ID: 12569428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Agonist-induced up-regulation of alpha4beta2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition.
    Whiteaker P; Sharples CG; Wonnacott S
    Mol Pharmacol; 1998 May; 53(5):950-62. PubMed ID: 9584223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methadone is a non-competitive antagonist at the α4β2 and α3* nicotinic acetylcholine receptors and an agonist at the α7 nicotinic acetylcholine receptor.
    Talka R; Salminen O; Tuominen RK
    Basic Clin Pharmacol Toxicol; 2015 Apr; 116(4):321-8. PubMed ID: 25196810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification and pharmacological profile of a new class of selective nicotinic acetylcholine receptor potentiators.
    Broad LM; Zwart R; Pearson KH; Lee M; Wallace L; McPhie GI; Emkey R; Hollinshead SP; Dell CP; Baker SR; Sher E
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1108-17. PubMed ID: 16738207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carbamoylcholine homologs: novel and potent agonists at neuronal nicotinic acetylcholine receptors.
    Jensen AA; Mikkelsen I; Frølund B; Bräuner-Osborne H; Falch E; Krogsgaard-Larsen P
    Mol Pharmacol; 2003 Oct; 64(4):865-75. PubMed ID: 14500743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term exposure to the new nicotinic antagonist 1,2-bisN-cytisinylethane upregulates nicotinic receptor subtypes of SH-SY5Y human neuroblastoma cells.
    Riganti L; Matteoni C; Di Angelantonio S; Nistri A; Gaimarri A; Sparatore F; Canu-Boido C; Clementi F; Gotti C
    Br J Pharmacol; 2005 Dec; 146(8):1096-109. PubMed ID: 16273122
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-n-alkylnicotinium analogs, a novel class of nicotinic receptor antagonists: interaction with alpha4beta2* and alpha7* neuronal nicotinic receptors.
    Wilkins LH; Grinevich VP; Ayers JT; Crooks PA; Dwoskin LP
    J Pharmacol Exp Ther; 2003 Jan; 304(1):400-10. PubMed ID: 12490617
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tobacco particulate matter is more potent than nicotine at upregulating nicotinic receptors on SH-SY5Y cells.
    Ambrose V; Miller JH; Dickson SJ; Hampton S; Truman P; Lea RA; Fowles J
    Nicotine Tob Res; 2007 Aug; 9(8):793-9. PubMed ID: 17654292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nicotinic receptor agonists and antagonists increase sAPPalpha secretion and decrease Abeta levels in vitro.
    Mousavi M; Hellström-Lindahl E
    Neurochem Int; 2009; 54(3-4):237-44. PubMed ID: 19111588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Noncompetitive inhibition of nicotinic acetylcholine receptors by endogenous molecules.
    Arias HR
    J Neurosci Res; 1998 May; 52(4):369-79. PubMed ID: 9589382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.